Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.8K Buy
252
+6
+2% +$693 0.01% 423
2026
Q1
$29.5K Sell
246
-21
-8% -$2.75K 0.01% 381
2025
Q4
$36.3K Buy
267
+2
+0.8% +$288 0.01% 321
2025
Q3
$39.1K Buy
265
+36
+16% +$4.99K 0.01% 285
2025
Q2
$29.6K Sell
229
-67
-23% -$8.11K 0.01% 286
2025
Q1
$35.3K Sell
296
-2
-0.7% -$248 0.02% 226
2024
Q4
$34.5K Buy
298
+10
+3% +$1.26K 0.02% 216
2024
Q3
$38.9K Buy
288
+24
+9% +$3.21K 0.02% 189
2024
Q2
$35.9K Buy
264
+4
+2% +$544 0.02% 166
2024
Q1
$33.6K Buy
260
+3
+1% +$362 0.02% 138
2023
Q4
$29.4K Buy
+257
New +$25.6K 0.03% 130

Other funds holding XYL

Dunhill Financial's XYL Position: Q2 2026 in Review

Dunhill Financial increased its Xylem (XYL) stake by 2.4% in Q2 2026, buying an estimated $693 and bringing the position to 252 shares worth $29.8K. The position accounts for 0.01% of the portfolio, ranked #423.

Dunhill Financial first reported a position in XYL in Q4 2023 and has held it in 11 quarters since. The position peaked at $39.1K in Q3 2025. 1,100 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Dunhill Financial held 252 shares of Xylem worth $29.8K as of Q2 2026.
  • Dunhill Financial bought 6 Xylem shares in Q2 2026, an estimated $693.
  • Xylem made up 0.01% of Dunhill Financial's portfolio in Q2 2026, its #423 holding.
  • Dunhill Financial first reported a position in Xylem in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Xylem position peaked at $39.1K in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.